Yango – Flexan – 90 capsules
17.16 €
Mængderabat
| Quantity | 2 | 3 | 4 | 5+ |
|---|---|---|---|---|
| Price | 16.30 € | 15.96 € | 15.62 € | 15.10 € |
11 in stock
Delivery time: 5–7 working days 🚚Discover Yango Flexan, a food supplement available in a convenient 90-capsule pack. This product is formulated with a blend of carefully selected ingredients, including glucosamine sulphate, chondroitin sulphate, MSM (methylsulfonylmethane), turmeric extract (Curcmin C3 Complex®), Boswellia serrata extract, vitamin C, microencapsulated vitamin D3, hyaluronic acid (sodium hyaluronate), and black pepper extract (BioPerine®).
Each capsule contains active components standardised for quality and consistency. The capsules are made with plant cellulose.
Ingredients
Ingredients: Glucosamine sulphate kcl (from crab and shrimp shells),chondroitin sulphate,methylsulfonylmethane (MSM),turmeric rhizome extract Curcmin C3 Complex® (curcuma longa) standardised to minimum 95% curcuminoids of which minimum 80% curcumin; Indian frankincense resin extract (Boswellia serrata) standardised to minimum 65% boswellic acids; L-ascorbic acid (vitamin C); microencapsulated vitamin D [carrier: modified starch,sucrose,medium-chain fatty acids; antioxidant: tocopherol mix],cholecalciferol (vitamin D); hyaluronic acid (sodium hyaluronate); black pepper fruit extract BioPerine® (Piper nigrum) standardised to minimum 95% piperine.
Capsule shell: plant cellulose.
Nutrition facts
| Active ingredient | 2 capsules | %NRV* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Glucosamine sulphate | 400 mg | – | |||||||
| MSM | 100 mg | – | |||||||
| turmeric Curcmin C3 Complex® – extract | 100 mg | – | |||||||
| of which curcuminoids (95%) | 95 mg | – | |||||||
| of which curcumin (80%) | 80 mg < td >– | ||||||||
100% < / t d > < tr > | K
yaluronic acid ( sodium hyaluronat e) < / td > |
10 m g < / td > |
– < / td > < / tr > | 2 m g < / th > | – < / th >
| 1.9 m g < / th > | – < / th > 50 ug << / th >> 1 0 0 0 % <<
/
th
>> >> warnings
|
Reviews
There are no reviews yet.